↓ Skip to main content

The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond

Overview of attention for article published in Frontiers in Pharmacology, October 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
Published in
Frontiers in Pharmacology, October 2018
DOI 10.3389/fphar.2018.01093
Pubmed ID
Authors

Pallavi R. Devchand, Tianyun Liu, Russ B. Altman, Garret A. FitzGerald, Eric E. Schadt

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 18%
Researcher 8 16%
Student > Bachelor 5 10%
Student > Master 5 10%
Other 2 4%
Other 4 8%
Unknown 18 35%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 18%
Pharmacology, Toxicology and Pharmaceutical Science 6 12%
Chemistry 5 10%
Unspecified 1 2%
Nursing and Health Professions 1 2%
Other 5 10%
Unknown 24 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2018.
All research outputs
#14,142,343
of 23,106,390 outputs
Outputs from Frontiers in Pharmacology
#4,432
of 16,460 outputs
Outputs of similar age
#184,279
of 344,304 outputs
Outputs of similar age from Frontiers in Pharmacology
#127
of 403 outputs
Altmetric has tracked 23,106,390 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,460 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,304 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 403 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.